Fatty Liver Change in Older Adults as an Important Risk Factor for Type 2 Diabetes: A Nationwide Cohort Study
Mayo Clinic Proceedings · 2023
DOI: 10.1016/j.mayocp.2023.02.033 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Mayo Clinic Proceedings, 2023. Verfasst von Kye-Yeung Park und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine, Hanyang University College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Prediabetic State, Non-alcoholic Fatty Liver Disease. Die Arbeit nennt 42 Literaturangaben.
Themen: Diabetes mellitus, Gerontologische Pflege
Abstract (Originalsprache)
OBJECTIVE: To examine the association between changes in fatty liver disease (FLD) over time and the risk of type 2 diabetes in elderly individuals with prediabetes. METHODS: A total of 156,984 elderly individuals with prediabetes who underwent national health screening in 2009 and 2011 were followed up through December 31, 2019. The FLD status was defined as a change in the fatty liver index. Prediabetes was defined as impaired fasting glucose levels at baseline. Multivariable Cox proportional hazards regression was used to calculate the hazard ratio and CIs for type 2 diabetes according to the changes in FLD. RESULTS: During a median of 8.35 years of follow-up, type 2 diabetes developed in 29,422 (18.7%) elderly individuals with prediabetes. Multivariable adjusted hazard ratio of type 2 diabetes according to FLD change was 2.22 (95% CI, 2.11 to 2.34) in individuals with persistent FLD compared with those who have never had FLD. Although overall weight loss of 5% or more was associated with a 7% lower risk of type 2 diabetes in total participants, fatty liver status was important. Even with weight loss, those with a history of fatty liver-resolved FLD, new FLD, or persistent FLD-had an increased risk of type 2 diabetes. The risk of type 2 diabetes did not increase in individuals with sustained FLD-free status, regardless of weight change. CONCLUSION: The presence and change of FLD are important factors for the development of type 2 diabetes in elderly individuals with prediabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Family Medicine, Hanyang University College of Medicine, Seoul, South Korea.
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, South Korea.
- Department of Statistics and Actuarial Science, Soongsil University, Seoul, South Korea.
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Hanyang University Guri Hospital, South Korea.
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Hanyang University Guri Hospital, South Korea. Electronic address: lanugo35@gmail.com.
Zitieren
APA
Park, K. Y., Park, J. H., Han, K., Yu, S. H., Lee, C. B., Kim, D. S., Park, H. K., Hwang, H. S., & Hong, S. (2023). Fatty Liver Change in Older Adults as an Important Risk Factor for Type 2 Diabetes: A Nationwide Cohort Study. Mayo Clinic Proceedings. https://doi.org/10.1016/j.mayocp.2023.02.033
Vancouver
Park KY, Park JH, Han K, Yu SH, Lee CB, Kim DS, et al. Fatty Liver Change in Older Adults as an Important Risk Factor for Type 2 Diabetes: A Nationwide Cohort Study. Mayo Clinic Proceedings. 2023. doi:10.1016/j.mayocp.2023.02.033
BibTeX
@article{Park2023,
author = {Park, Kye-Yeung and Park, Jung Hwan and Han, Kyungdo and Yu, Sung Hoon and Lee, Chang Beom and Kim, Dong Sun and Park, Hoon-Ki and Hwang, Hwan-Sik and Hong, Sangmo},
title = {Fatty Liver Change in Older Adults as an Important Risk Factor for Type 2 Diabetes: A Nationwide Cohort Study},
journal = {Mayo Clinic Proceedings},
year = {2023},
doi = {10.1016/j.mayocp.2023.02.033}
}
EUVIMED